Handelsbanken Fonder’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-929
| Closed | -$10K | – | 1610 |
|
|
2023
Q1 | $10K | Hold |
929
| – | – | ﹤0.01% | 1563 |
|
|
2022
Q4 | $31K | Hold |
929
| – | – | ﹤0.01% | 1554 |
|
|
2022
Q3 | $45K | Hold |
929
| – | – | ﹤0.01% | 1560 |
|
|
2022
Q2 | $53K | Sell |
929
-1,373
| -60% | -$78.3K | ﹤0.01% | 1605 |
|
|
2022
Q1 | $186K | Hold |
2,302
| – | – | ﹤0.01% | 1643 |
|
|
2021
Q4 | $467K | Hold |
2,302
| – | – | ﹤0.01% | 1398 |
|
|
2021
Q3 | $620K | Hold |
2,302
| – | – | ﹤0.01% | 1209 |
|
|
2021
Q2 | $593K | Hold |
2,302
| – | – | ﹤0.01% | 1253 |
|
|
2021
Q1 | $691K | Hold |
2,302
| – | – | ﹤0.01% | 1022 |
|
|
2020
Q4 | $587K | Hold |
2,302
| – | – | ﹤0.01% | 1076 |
|
|
2020
Q3 | $573K | Hold |
2,302
| – | – | ﹤0.01% | 934 |
|
|
2020
Q2 | $800K | Buy |
+2,302
| New | +$800K | 0.01% | 773 |
|
|
2019
Q3 | – | Sell |
-3,936
| Closed | -$2.1M | – | 189 |
|
|
2019
Q2 | $2.1M | Sell |
3,936
-1,080
| -22% | -$576K | 0.04% | 171 |
|
|
2019
Q1 | $2.53M | Buy |
5,016
+747
| +17% | +$376K | 0.05% | 165 |
|
|
2018
Q4 | $2.11M | Buy |
4,269
+902
| +27% | +$445K | 0.04% | 157 |
|
|
2018
Q3 | $3.08M | Buy |
3,367
+1,334
| +66% | +$1.22M | 0.06% | 159 |
|
|
2018
Q2 | $1.49M | Sell |
2,033
-1,167
| -36% | -$855K | 0.03% | 176 |
|
|
2018
Q1 | $5.1M | Sell |
3,200
-1,400
| -30% | -$2.23M | 0.1% | 147 |
|
|
2017
Q4 | $4.12M | Buy |
+4,600
| New | +$4.12M | 0.09% | 143 |
|